Editor-in-Chief: Professor Gary Maartens

The Southern African Journal of HIV Medicine (SAJHIVMED), under the leadership of Editor-in-Chief Professor Gary Maartens, invites you to submit a manuscript for publication. Authors from all countries, not just southern Africa, are encouraged to submit. 

Being DHET and PubMed Central® accredited the SAJHIVMED focuses on HIV management and prevention, and other related topics relevant to clinical and public health practice.

The purpose of the journal is to disseminate research and to support high-level learning related to HIV medicine. The journal publishes original research articles, editorials, case reports/case series, and reviews of state-of-the-art clinical practice.

Manuscripts are published on an ongoing basis and are open access. Papers are double-blind peer-reviewed, and it takes approximately 30 days following submission for the first decision to be communicated with authors. 

Read about the benefits of open access to authors and readers.

Learn more:

• Submission guidelines
• Submission procedure
• Publication fees

Submit your latest research for consideration, contribute to the open-access content available to everyone, and share your expertise with a wider audience.

‘Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART’ authored by Ying Zhao, Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens and Graeme Meintjes is on its way. Stay tuned for thought-provoking insights and valuable information coming your way 26 April 2024! Contribution excerpt: ‘This study supports switching to TLD as a third-line regimen or an alternative second-line regimen after PI regimen failure in a programmatic setting, with the caveat that patients switched to TLD in our study had no tenofovir resistance.'